论文部分内容阅读
目的探讨双歧杆菌二联活菌散防治婴幼儿肺炎继发性腹泻的实际临床疗效。方法我院自2011年7月至2012年7月收治婴幼儿肺炎患儿80例,随机分为治疗组和对照组,每组各40例,两组患儿均给予抗生素及对症治疗,治疗组在此基础上给予双歧杆菌二联活菌散口服治疗,统计两组患儿实际临床治疗效果。结果治疗组患儿继发腹泻8例,对照组患儿继发腹泻19例。两组患儿继发腹泻发生率相比较,治疗组显著低于对照组,差异具有统计学意义(P<0.05)。结论双歧杆菌二联活菌散防治婴幼儿肺炎继发性腹泻实际临床疗效显著。
Objective To explore the practical clinical efficacy of Bifidobacterium and Bifidobacterium spp in prevention and treatment of secondary diarrhea of infantile pneumonia. Methods 80 cases of infantile pneumonia were treated in our hospital from July 2011 to July 2012. They were randomly divided into treatment group and control group, 40 cases in each group. Antibiotics and symptomatic treatment were given in both groups. The treatment group On this basis, Bifidobacterium given oral live oral treatment, the actual clinical treatment of children in both groups. Results In the treatment group, 8 cases of secondary diarrhea and 19 cases of secondary diarrhea in the control group. Two groups of children with secondary diarrhea incidence compared to the treatment group was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion Bifidobacterium two live bacteria powder prevention and treatment of infant secondary pneumonia secondary diarrhea clinical efficacy significantly.